If tirzepatide is producing the desired outcomes, there is no compelling reason to switch to a less proven compound with more side effects
Key Details of the GLP-1 Bridge Program Timeline Start date: July 1, 2026 End date: December 31, 2027 Transition: The BALANCE Model launches January 1, 2027 and will run alongside the Bridge through 2027 Which Drugs Are Covered
GLP-1s can lower food noise and may boost self-efficacy for health, said Cook
The effects of lipotropic injections are temporary, so they must be administered regularly by your health care provider
Our guide on how long peptides take to work provides additional context for setting realistic expectations, and peptide before and after results from the research community illustrate the range of outcomes people experience
Patients who need treatment now have a clear path